France (FR)

Towards personalized mapping through lumbosacral spinal cord task fMRI (2025) Hernandez-Charpak SD, Kinany N, Ricchi I, Schlienger R, Mattera L, Martuzzi R, Nazarian B, et al. Journal article Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability (2025) Sabeh P, Dumas SA, Maios C, Daghar H, Korzeniowski M, Rousseau J, Lines M, et al. Journal article The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus. (2025) Pfob A, Pinker K, Vaz-Luis I, Di Meglio A, Cardoso MJ, Curigliano G, Gentilini OD, et al. Journal article, Review article Anterior temporal lobectomy and selective AmygdaloHippocampectomy complications across Europe: review, meta-analysis, and Delphi consensus. (2025) Karagianni MD, Schijns OE, Brotis A, Tasiou A, Auer C, Blauwblomme T, Budke M, et al. Journal article, Review article The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective. (2025) Van Den Bent MJ, Cloughesy TF, Ellingson BM, Allen JE, Blackman SC, Kieran MW, Tonn JC, et al. Journal article, Review article A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. (2025) Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, et al. Journal article Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. (2025) Colalillo A, Pellicano C, Ananyeva LP, Hachulla E, Cuomo G, Györfi AH, Czirják L, et al. Journal article Global tuning of hadronic interaction models with accelerator-based and astroparticle data (2025) Albrecht J, Becker Tjus J, Behling N, Blazek J, Bleicher M, Boelhauve J, Cazon L, et al. Journal article, Review article A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication (2025) Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ibáñez L, Carlsson M, Cutfield W, et al. Journal article, Review article Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial (2025) Tsianakas A, Passeron T, Magnolo N, Blume-Peytavi U, Kelly V, Day I, Serrao R, et al. Journal article